AU Patent

AU2006205920B2 — Thiazole-4-carboxamide derivatives as mGluR5 antagonists

Assigned to F Hoffmann La Roche AG · Expires 2012-11-15 · 14y expired

What this patent protects

The present invention is concerned with novel thiazole 4-carboxyamide derivatives of the general formula (I) and with methods for the preparation thereof, which compounds are useful as metabotropic glutamate receptor antagonists: wherein R to R are as defined in the specification…

USPTO Abstract

The present invention is concerned with novel thiazole 4-carboxyamide derivatives of the general formula (I) and with methods for the preparation thereof, which compounds are useful as metabotropic glutamate receptor antagonists: wherein R to R are as defined in the specification.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006205920B2
Jurisdiction
AU
Classification
—
Expires
2012-11-15
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.